CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Curaleaf Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.20 (-2.55%)
Close on Oct 19, 2026
- Market cap
- $2.07B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.98 (−11.35%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Curaleaf Holdings, Inc. saw revenue fall 5.0% to $1.27B over fiscal 2025. Operating income rose 2.9% to $25.45M, moving the operating margin from 1.9% to 2.0%. Free cash flow was $74.27M, up 4.3% from a year earlier.
Revenue
$1.27B
-5.0% vs. a year earlier
Operating income
$25.45M
+2.9% vs. a year earlier
Free cash flow
$74.27M
+4.3% vs. a year earlier
EPS, diluted
-$1.05
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $2.07B
- P/E ratio
- –
- Price to sales
- 1.63
- Price to book
- 2.38
- Dividend yield
- –
- Free cash flow yield
- 3.60%
Fundamentals
- Revenue
- $1.27B
- Net income
- -$231.07M
- EPS, diluted
- -$1.05
- Free cash flow
- $74.27M
- Book value per share
- $3.20
- Diluted shares
- 271M
Eight years at a glance
Fiscal years 2018 to 2025, USD
Revenue
$1.27B-5.0% YoY
Gross profit
$631.02M-1.5% YoY
Operating income
$25.45M+2.9% YoY
Net income
-$231.07M
EPS, diluted
-$1.05
Free cash flow
$74.27M+4.3% YoY
Reported period